Table 3

Zidovudine susceptibility analysis

Resistance-associated amino acid in RT
40
41
43
184
210
215
219
Average


Fold
Consensus B
E
M
K
M
L
T
K
IC50 (nM)


Increase

Wild type (HXB2)
.
.
.
.
.
.
.
114
±
10

Wild type+K43E
.
.
E
.
.
.
.
90
±
36

M41L+T215Y
.
L
.
.
.
Y
.
1544
±
402
14×
M41L+T215Y+E40F
F
L
.
.
.
Y
.
21307
±
8810
187×
M41L+T215Y+K43E
.
L
E
.
.
Y
.
1556
±
496
14×
M41L+T215Y+E40F+K43E
F
L
E
.
.
Y
.
15350
±
5022
135×

Pat A
F
L
E
V
W
Y
T
14739
±
3105
129×
Pat A-WT40
.
L
E
V
W
Y
T
1596
±
377
14×
Pat A-WT43
F
L
.
V
W
Y
T
13127
±
4582
115×

Pat A-derived virus clone revealed additional amino acid changes including T200I, R211K, V245T, E248D, I293V and E297H

The mean IC50 values of at least two experiments are shown (± standard error of the mean); in the most right column the fold increase compared to the wild type HIV-1 HXB2 reference strain is shown.

Huigen et al. Retrovirology 2008 5:20   doi:10.1186/1742-4690-5-20

Open Data